China Hormone Refractory Prostate Cancer Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Hormone Refractory Prostate Cancer industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Dendreon Corporation, Bayer AG

    • Sanofi SA

    • Astellas Inc

    By Type:

    • Hormonal Therapy

    • Immunotherapy

    • Surgery

    • Radiation Therapy

    • Chemotherapy

    By Application:

    • Specialty Clinics

    • Ambulatory Surgical Centers

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Hormone Refractory Prostate Cancer Market Overview 2018-2029

    • 1.1 China Hormone Refractory Prostate Cancer Industry Development Overview

    • 1.2 China Hormone Refractory Prostate Cancer Industry Development History

    • 1.3 China Hormone Refractory Prostate Cancer Industry Market Size (2018-2029)

    • 1.4 China Hormone Refractory Prostate Cancer Market Analysis by Type from Production Side

      • 1.4.1 China Hormone Refractory Prostate Cancer Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)

      • 1.4.2 China Hormone Refractory Prostate Cancer Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

      • 1.4.3 China Hormone Refractory Prostate Cancer Production Volume, Production Value and Growth Rate of Surgery (2018-2029)

      • 1.4.4 China Hormone Refractory Prostate Cancer Production Volume, Production Value and Growth Rate of Radiation Therapy (2018-2029)

      • 1.4.5 China Hormone Refractory Prostate Cancer Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)

    • 1.5 China Hormone Refractory Prostate Cancer Market Analysis by Application from Consumption End

      • 1.5.1 China Hormone Refractory Prostate Cancer Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)

      • 1.5.2 China Hormone Refractory Prostate Cancer Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

      • 1.5.3 China Hormone Refractory Prostate Cancer Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Hormone Refractory Prostate Cancer Market Analysis by Region

      • 1.6.1 North China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

    Chapter 2 China Hormone Refractory Prostate Cancer Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Hormone Refractory Prostate Cancer Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Hormone Refractory Prostate Cancer Market Status and Competition Analysis in 2023

      • 2.2.3 China Hormone Refractory Prostate Cancer Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Hormone Refractory Prostate Cancer Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Hormone Refractory Prostate Cancer Industry Development

    Chapter 3 Hormone Refractory Prostate CancerIndustry Chain Analysis

    • 3.1 Hormone Refractory Prostate Cancer Industry Chain

    • 3.2 Hormone Refractory Prostate Cancer Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Hormone Refractory Prostate Cancer Market

    • 3.3 Hormone Refractory Prostate Cancer Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Hormone Refractory Prostate Cancer Market

    Chapter 4 China Hormone Refractory Prostate Cancer Market, by Type

    • 4.1 China Hormone Refractory Prostate Cancer Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Hormone Refractory Prostate Cancer Total Production Volume and Growth Rate from Production Side

    • 4.5 China Hormone Refractory Prostate Cancer Production Volume and Growth Rate, by Type

      • 4.5.1 China Hormone Refractory Prostate Cancer Production Volume and Growth Rate of Hormonal Therapy

      • 4.5.2 China Hormone Refractory Prostate Cancer Production Volume and Growth Rate of Immunotherapy

      • 4.5.3 China Hormone Refractory Prostate Cancer Production Volume and Growth Rate of Surgery

      • 4.5.4 China Hormone Refractory Prostate Cancer Production Volume and Growth Rate of Radiation Therapy

      • 4.5.5 China Hormone Refractory Prostate Cancer Production Volume and Growth Rate of Chemotherapy

    Chapter 5 China Hormone Refractory Prostate Cancer Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Hormone Refractory Prostate Cancer Total Market Size and Growth Rate from Consumption End

    • 5.5 China Hormone Refractory Prostate Cancer Market Size and Growth Rate, by Application

      • 5.5.1 China Hormone Refractory Prostate Cancer Market Size and Growth Rate of Specialty Clinics

      • 5.5.2 China Hormone Refractory Prostate Cancer Market Size and Growth Rate of Ambulatory Surgical Centers

      • 5.5.3 China Hormone Refractory Prostate Cancer Market Size and Growth Rate of Hospitals

    Chapter 6 China Hormone Refractory Prostate Cancer Market, by Region

    • 6.1 China Hormone Refractory Prostate Cancer Production Volume and Production Value, by Region

    • 6.2 China Hormone Refractory Prostate Cancer Sales Volume and Sales Value, by Region

    Chapter 7 North China Hormone Refractory Prostate Cancer Market Analysis

    • 7.1 North China Hormone Refractory Prostate Cancer Market, by Type

    • 7.2 North China Hormone Refractory Prostate Cancer Market, by Application

    Chapter 8 Central China Hormone Refractory Prostate Cancer Market Analysis

    • 8.1 Central China Hormone Refractory Prostate Cancer Market, by Type

    • 8.2 Central China Hormone Refractory Prostate Cancer Market, by Application

    Chapter 9 South China Hormone Refractory Prostate Cancer Market Analysis

    • 9.1 South China Hormone Refractory Prostate Cancer Market, by Type

    • 9.2 South China Hormone Refractory Prostate Cancer Market, by Application

    Chapter 10 East China Hormone Refractory Prostate Cancer Market Analysis

    • 10.1 East China Hormone Refractory Prostate Cancer Market, by Type

    • 10.2 East China Hormone Refractory Prostate Cancer Market, by Application

    Chapter 11 Northeast China Hormone Refractory Prostate Cancer Market Analysis

    • 11.1 Northeast China Hormone Refractory Prostate Cancer Market, by Type

    • 11.2 Northeast China Hormone Refractory Prostate Cancer Market, by Application

    Chapter 12 Southwest China Hormone Refractory Prostate Cancer Market Analysis

    • 12.1 Southwest China Hormone Refractory Prostate Cancer Market, by Type

    • 12.2 Southwest China Hormone Refractory Prostate Cancer Market, by Application

    Chapter 13 Northwest China Hormone Refractory Prostate Cancer Market Analysis

    • 13.1 Northwest China Hormone Refractory Prostate Cancer Market, by Type

    • 13.2 Northwest China Hormone Refractory Prostate Cancer Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Dendreon Corporation, Bayer AG

        • 14.1.1 Dendreon Corporation, Bayer AG Company Profile

        • 14.1.2 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sanofi SA

        • 14.2.1 Sanofi SA Company Profile

        • 14.2.2 Sanofi SA Hormone Refractory Prostate Cancer Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Astellas Inc

        • 14.3.1 Astellas Inc Company Profile

        • 14.3.2 Astellas Inc Hormone Refractory Prostate Cancer Market Performance

        • 14.3.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Hormone Refractory Prostate Cancer Industry Research Conclusions

    • 15.2 Hormone Refractory Prostate Cancer Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Hormone Refractory Prostate Cancer Industry Market Size (2018-2029)

    • Figure China Hormone Refractory Prostate Cancer Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)

    • Figure China Hormone Refractory Prostate Cancer Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

    • Figure China Hormone Refractory Prostate Cancer Production Volume, Production Value and Growth Rate of Surgery (2018-2029)

    • Figure China Hormone Refractory Prostate Cancer Production Volume, Production Value and Growth Rate of Radiation Therapy (2018-2029)

    • Figure China Hormone Refractory Prostate Cancer Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)

    • Figure China Hormone Refractory Prostate Cancer Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)

    • Figure China Hormone Refractory Prostate Cancer Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • Figure China Hormone Refractory Prostate Cancer Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

    • Figure Central China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

    • Figure South China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

    • Figure East China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Hormone Refractory Prostate Cancer Market Size and Growth Rate from 2018-2029

    • Figure Hormone Refractory Prostate Cancer Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Hormone Refractory Prostate Cancer Market Share by Type in 2018

    • Figure China Hormone Refractory Prostate Cancer Market Share by Type in 2023

    • Figure China Hormone Refractory Prostate Cancer Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Production Volume and Growth Rate of Hormonal Therapy (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Production Volume and Growth Rate of Immunotherapy (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Production Volume and Growth Rate of Surgery (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Production Volume and Growth Rate of Radiation Therapy (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Production Volume and Growth Rate of Chemotherapy (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Market Share by Application in 2018

    • Figure China Hormone Refractory Prostate Cancer Market Share by Application in 2023

    • Figure China Hormone Refractory Prostate Cancer Total Market Size and Growth Rate from Consumption End

    • Figure China Hormone Refractory Prostate Cancer Market Size and Growth Rate of Specialty Clinics (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Market Size and Growth Rate of Ambulatory Surgical Centers (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Hormone Refractory Prostate Cancer Production Volume by Region (2018-2023)

    • Table China Hormone Refractory Prostate Cancer Production Volume Share by Region (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Production Volume Share by Region (2018-2023)

    • Table China Hormone Refractory Prostate Cancer Production Value by Region (2018-2023)

    • Table China Hormone Refractory Prostate Cancer Production Value Share by Region (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Production Value Share by Region (2018-2023)

    • Table China Hormone Refractory Prostate Cancer Sales Volume by Region (2018-2023)

    • Table China Hormone Refractory Prostate Cancer Sales Volume Share by Region (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Sales Volume Share by Region (2018-2023)

    • Table China Hormone Refractory Prostate Cancer Sales Value by Region (2018-2023)

    • Table China Hormone Refractory Prostate Cancer Sales Value Share by Region (2018-2023)

    • Figure China Hormone Refractory Prostate Cancer Sales Value Share by Region (2018-2023)

    • Table North China Hormone Refractory Prostate Cancer Production Volume by Type (2018-2023)

    • Table North China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Figure North China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Table North China Hormone Refractory Prostate Cancer Sales Volume by Application (2018-2023)

    • Table North China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Figure North China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Table Central China Hormone Refractory Prostate Cancer Production Volume by Type (2018-2023)

    • Table Central China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Figure Central China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Table Central China Hormone Refractory Prostate Cancer Sales Volume by Application (2018-2023)

    • Table Central China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Figure Central China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Table South China Hormone Refractory Prostate Cancer Production Volume by Type (2018-2023)

    • Table South China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Figure South China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Table South China Hormone Refractory Prostate Cancer Sales Volume by Application (2018-2023)

    • Table South China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Figure South China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Table East China Hormone Refractory Prostate Cancer Production Volume by Type (2018-2023)

    • Table East China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Figure East China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Table East China Hormone Refractory Prostate Cancer Sales Volume by Application (2018-2023)

    • Table East China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Figure East China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Table Northeast China Hormone Refractory Prostate Cancer Production Volume by Type (2018-2023)

    • Table Northeast China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Figure Northeast China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Table Northeast China Hormone Refractory Prostate Cancer Sales Volume by Application (2018-2023)

    • Table Northeast China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Table Southwest China Hormone Refractory Prostate Cancer Production Volume by Type (2018-2023)

    • Table Southwest China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Figure Southwest China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Table Southwest China Hormone Refractory Prostate Cancer Sales Volume by Application (2018-2023)

    • Table Southwest China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Table Northwest China Hormone Refractory Prostate Cancer Production Volume by Type (2018-2023)

    • Table Northwest China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Figure Northwest China Hormone Refractory Prostate Cancer Production Volume Share by Type (2018-2023)

    • Table Northwest China Hormone Refractory Prostate Cancer Sales Volume by Application (2018-2023)

    • Table Northwest China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Hormone Refractory Prostate Cancer Sales Volume Share by Application (2018-2023)

    • Table Dendreon Corporation, Bayer AG Company Profile

    • Table Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Hormone Refractory Prostate Cancer Revenue, Price and Gross (2018-2023)

    • Table Astellas Inc Company Profile

    • Table Astellas Inc Hormone Refractory Prostate Cancer Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.